Is Apple Inc. (AAPL) the Best High Volume Stock to Buy Now?
We recently published a list of the 13 Best High Volume Stocks to Buy Now. In this article, we are going to take a look at where Apple Inc. (NASDAQ:AAPL) stands against other best high volume stocks.
On May 9, BMO private wealth chief market strategist Carol Schleif joined CNBC's 'Squawk Box' to discuss the latest market trends and the state of the economy. Reflecting on a market decline in April that reached a ~20% drop, Schleif noted that the market recovered and ended only 3% to 4 % down. She described investor reactions during that period as mixed: about 10% were very eager to buy, but another 10% were quite nervous, while the majority remained measured. She emphasized the important distinction between markets and the economy and noted that markets often move ahead of economic realities and quickly shift focus to new topics as part of their discounting mechanism. This is why markets serve as economic indicators and anticipate future developments.
She talked about how individual risk tolerance varies, with some younger clients adopting conservative strategies and some older clients favoring aggressive positions, especially in tech. Schleif acknowledged that tariffs are expected to rise from under 3% to ~10%, but despite this anticipation, she's confident that markets and companies will adjust to the changes. She noted the unusual shift in US influence, which now extends beyond material control to more intangible domains, and described this shift in responsibility as significant and complex. Schleif also emphasized the value of globally diversified portfolios, which have been challenging to maintain during periods when the US market outperformed. However, she noted that such diversification, which includes fixed income and foreign equities, has provided better performance and protection year-to-date and helps investors weather volatility better than those concentrated solely in US assets.
We first used stock screeners to compile a list of stocks with high average 3-month volumes. We then selected the 13 stocks that were the most popular among elite hedge funds and that analysts were bullish on. The stocks are ranked in ascending order of the number of hedge funds that have stakes in them, as of Q4 2024.
Note: All data was collected on May 12.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
A wide view of an Apple store, showing the range of products the company offers.Number of Hedge Fund Holders: 166
Apple Inc. (NASDAQ:AAPL) designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories. It offers iPhones, Macs, iPads, AirPods, Apple TV, Apple Watch, Beats products, and HomePod. It also provides AppleCare support and cloud services, and operates various platforms like the App Store.
While Apple operates across various product categories, a significant driver of its revenue and growth is its Services segment. In FQ2 2025, the company's Services segment achieved an all-time revenue record of $26.6 billion, which was up 12% year-over-year. The Services segment encompasses offerings like the App Store, Apple Music, iCloud, and Apple Pay. Both transacting and paid accounts in this segment reached new all-time highs, with paid accounts growing by double digits year-over-year.
Apple now boasts well over 1 billion paid subscriptions across its Services platform. Morgan Stanley analyst Erik Woodring raised the price target on Apple Inc. (NASDAQ:AAPL) to $235 from $220 on April 29 and kept an Overweight rating. The firm expects June quarter guidance to modestly exceed consensus, despite some downside given the current tariff situation.
Columbia Seligman Global Technology Fund maintained its position in the company and stated the following regarding Apple Inc. (NASDAQ:AAPL) in its Q4 2024 investor letter:
'The fund maintained a position in Apple Inc. (NASDAQ:AAPL) throughout the quarter through the release of the company's new iPhone 16 in September. Company leaders were excited about the release of the new model, as this is the first model that will feature enhanced AI capabilities through the Apple Intelligence features. Sales for the first few weeks in October and November trailed behind year over year sales from the iPhone 15, as availability of Apple Intelligence was not compatible with all iPhone models. Apple announced a partnership with OpenAI that has allowed the integration of ChatGPT into the Apple ecosystem, separate from the core Apple Intelligence features. This partnership highlights continued progress from Apple to introduce AI capabilities into its products and we expect the iPhone 17 to have even more expansive AI capabilities, increasing potential demand for the new model that is on track to be released in 2025.'
Overall, AAPL ranks 3rd on our list of the best high volume stocks to buy now. While we acknowledge the growth potential of AAPL, our conviction lies in the belief that AI stocks hold great promise for delivering high returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than AAPL but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
The $1.3 Billion Health-Tech IPO Everyone Missed--Until It Soared 21% on Day One
Omada Health (NASDAQ:OMDA) opened its first day of trading with a bangjumping 21% to $23 after pricing its IPO at $19. That move gives the digital chronic-care startup a market cap of roughly $1.3 billion. The $150 million raise was more than just well receivedinvestor demand came in more than 15x oversubscribed, with most allocations going to a concentrated group of institutional buyers. It's another sign that appetite for health-tech IPOs is heating up again. U.S. listings have raised nearly $25 billion year-to-date, and early-stage healthcare names are up an average of 18% since listing. Founded in 2011, Omada offers virtual care between doctor visitsfocused on diabetes, obesity, hypertension, and joint pain. What sets it apart? It's not chasing the GLP-1 gold rush. Instead, Omada supports people already on those drugs, helping them manage side effects, nutrition, and post-treatment maintenance. About 50,000 of its 679,000 members are on GLP-1s. CEO Sean Duffy told Bloomberg that while AI powers much of the back-end, real human interaction is what drives results. Our members tell us they want a personand I have yet to see anyone that feels accountable to ChatGPT, he said. Revenue for Q1 2025 came in just under $55 millionup from $35.1 million a year agowhile net losses narrowed by more than half to $9.4 million. That improving financial picture, combined with a clear niche in chronic care, could be what's drawing top-tier investors. Revelation Partners, Andreessen Horowitz, Fidelity, and USVP are all among the largest shareholders. The IPO was led by Morgan Stanley, Goldman Sachs, and JPMorgan. OMDA now trades on the Nasdaq Global Marketand it's one more sign that digital health might be staging a real comeback. This article first appeared on GuruFocus.


CNBC
20 minutes ago
- CNBC
CNBC TechCheck Evening Edition: June 6, 2025
CNBC's TechCheck brings you the latest in tech news from CNBC's 1 Market in the heart of San Francisco.
Yahoo
24 minutes ago
- Yahoo
Omada Health Soars 42% in Nasdaq Debut After $150 Million IPO
Omada Health (OMDA, Financials) surged 42% in its Nasdaq debut Friday after the virtual chronic care company priced its initial public offering at $19 per share, raising $150 million and securing a valuation just above $1 billion. The stock opened at $23 and climbed quickly past $27. Warning! GuruFocus has detected 8 Warning Sign with X. Founded in 2012, Omada offers virtual programs for chronic conditions including prediabetes, diabetes, and hypertension. The IPO, which sold 7.9 million shares, is part of a recent resurgence in health and tech listings, following last month's debut of Hinge Health and Thursday's surge in Circle Internet shares. In its prospectus, Omada reported Q1 revenue jumped 57% year over year to $55 million, while full-year 2024 revenue rose 38% to $169.8 million. The company narrowed its net loss in the most recent quarter to $9.4 million from $19 million a year earlier. Major outside shareholders include U.S. Venture Partners, Andreessen Horowitz, and Fidelity's FMR LLC, each holding a 9% to 10% stake. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data